摘要
基因重组人脑利钠肽已经成为急性心力衰竭的一线用药,是慢性心力衰竭的重要治疗手段,将来也可能成为急性心肌梗死重要的治疗方法。
RhBNP has become the first line medicine in treatment of acute heart failure, and the important treatment measure for chronic cardiac failure. RhBNP could become an important measure for acute myocardial infarction.
出处
《现代预防医学》
CAS
北大核心
2008年第16期3235-3237,共3页
Modern Preventive Medicine